Literature DB >> 21736571

Cesium cessation? An advantage of pathogen reduction treatments.

Paul D Mintz.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21736571     DOI： 10.1111/j.1537-2995.2011.03201.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  3 in total

1.  Treatment of buffy coat platelets in platelet additive solution with the mirasol(®) pathogen reduction technology system.

Authors:  Azucena Castrillo; Marcia Cardoso; Lindsay Rouse
Journal:  Transfus Med Hemother       Date:  2013-01-03       Impact factor: 3.747

2.  Cost implications of implementation of pathogen-inactivated platelets.

Authors:  Jeffrey McCullough; Dennis Goldfinger; Jed Gorlin; William J Riley; Harpreet Sandhu; Christopher Stowell; Dawn Ward; Mary Clay; Shelley Pulkrabek; Vera Chrebtow; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-05-18       Impact factor: 3.157

3.  Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.

Authors:  Steve Kleinman; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-08-25       Impact factor: 3.157
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.